MDGL
MADRIGAL PHARMACEUTICALS, INC.
MADRIGAL PHARMACEUTICALS, INC. (MDGL) has 11 SEC Form 4 filings (61 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jun 18, 2026.
The most active filer is Director FRIEDMAN PAUL A with 3 filings. Insiders have net sold $517K over the trailing 6 months.
- Industry:Biotechnology
- CEO:William J. Sibold
- Employees:528
- HQ:West Conshohocken, PA, US
- IPO:2007-02-06
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$85.1M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$12.7B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Soergel DavidFirst filing | Chief Medical Officer | Sale | 1,042 | $517K | Jun 1 | SEC ↗ |
BATE KENNETHFirst filing | Director | Sale | 10,000 | $3.7M | Aug 15 | SEC ↗ |
FRIEDMAN PAUL AFirst filing | Director | Sale | 3,203 | $1.1M | Aug 13 | SEC ↗ |
FRIEDMAN PAUL AFirst filing | Director | Sale | 43,605 | $15.5M | Aug 13 | SEC ↗ |
Taub RebeccaFirst filing | Director | Sale | 3,200 | $1.1M | Aug 13 | SEC ↗ |
Taub RebeccaFirst filing | Director | Sale | 43,263 | $15.4M | Aug 13 | SEC ↗ |
FRIEDMAN PAUL AFirst filing | Director | Sale | 129,172 | $47.8M | Aug 13 | SEC ↗ |
Related companies
MADRIGAL PHARMACEUTICALS, INC. is in the Healthcare sector.